Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

EWER K., FLAXMAN A., JENKIN D., ABOAGYE J.

Type

Journal article

Journal

The Lancet

Publisher

Elsevier

Publication Date

01/09/2021

Permalink